---

Therapy studies inclusive of acute, lymphoma, and progressing or poor prognosis chronic ATLL (Adult T-cell leukemia/lymphoma)

Range	Table - link
Organism	Human Homo sapiens
Reference	Taylor GP, Matsuoka M. Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene. 2005 Sep 5 24(39):6047-57. DOI: 10.1038/sj.onc.1208979 p.6052 table 1PubMed ID16155611
Primary Source	See pointers to refs in left column of table
Method	See "Therapy" column
Comments	P.6051 left column 2nd paragraph: "Overall, ATLL survival with various chemotherapy regimens is poor, with survival in several cohorts of patients presenting predominantly with acute leukemia or lymphoma ranging between 5.5 and 13 months. This approach does not offer the prospect of cure (Table 1)."
Entered by	Uri M
ID	113600